DSM provides 2008 and Q1 2009 comparative figures

Royal DSM N.V. today provides the investment community with comparative quarterly figures for 2008 and Q1 2009. These comparative figures reflect the reclassification of DSM Energy and Stamicarbon from the Base Chemicals & Materials cluster to discontinued operations as well as the reclassification of DSM's participation in Noordgastransport from Other activities to discontinued operations. These reclassifications follow on the announced intended disposals of these businesses. The comparative figures can be found in the annex to this press release and can also be downloaded from the Investors section on the DSM corporate website, www.dsm.com. DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Hans Vossen tel. +31 (0) 45 tel. +31 (0) 45 5782864 5782017 fax +31 (0) 45 5782595 fax +31 (0) 45 e-mail 5740680 investor.relations@dsm.com e-mail media.relations@dsm.com This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.